Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference26 articles.
1. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing;Ducimetiere;PLoS One,2011
2. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial;Schoffski;Lancet,2016
3. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial;Judson;Lancet Oncol,2014
4. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
5. Adriamycin: a new effective agent in the therapy of disseminated sarcomas;Benjamin;Med Pediatr Oncol,1975
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liver metastasis in soft tissue sarcoma at initial presentation;Journal of Surgical Oncology;2022-07-06
2. Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma;Clinical Cancer Research;2022-02-21
3. A case of pulmonary leiomyosarcoma achieving long-term survival after multiple metastasectomies;International Cancer Conference Journal;2022-02-14
4. RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report;Frontiers in Oncology;2021-08-30
5. The systemic treatment of uterine leiomyosarcomas;Medicine;2021-04-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3